Events
Featured Events
Despite toxicity concerns for CD47 targets in 2023, the macrophage therapies space remains determined to drive revolutionary treatments for oncology, autoimmunity, inflammation, neurodegenerative disorders, and beyond. From pioneering the next generation of CAR-M therapies to unveiling novel targets, this field is on a mission to learn from the past and spearhead pipelines into clinical development.
With that, the 6th Macrophage-Directed Therapies Summit will return to Boston this year, uniting 60+ biopharma and academia leaders across R and D, Discovery, Biology, Translational, and Clinical Development fields. As a uniquely positioned platform, this event is perfect for those committed to reigniting excitement in macrophage pipeline advancement.
This is your chance to gain exclusive insig…
With Kenai Therapeutics emerging from stealth with an $82 Million Series A funding round, 2024 has started strong for iPSC drug developers looking to showcase the potential of their pipelines ahead of the next wave of investment.
The 4th iPSC Drug Development and Manufacturing Summit is your longest standing and definitive iPSC focused industry platform showcasing cutting-edge advances across R and D through to manufacturing and analytical development to help you stay at the forefront of the iPSC cell therapy revolution.
With content split across our Research and Development and Manufacturing and Analytical Development tracks, this is the one-stop shop meeting for drug developers and academic thought leaders looking to streamline their route to the clinic and scale up their manufacturing p…
Attention all Macrophage Experts! ๐ข
If you're looking to learn from the past and ๐ฝ๐ฟ๐ผ๐ฝ๐ฒ๐น ๐๐ผ๐๐ฟ ๐บ๐ฎ๐ฐ๐ฟ๐ผ๐ฝ๐ต๐ฎ๐ด๐ฒ ๐๐ต๐ฒ๐ฟ๐ฎ๐ฝ๐ถ๐ฒ๐ ๐๐ผ ๐ฐ๐น๐ถ๐ป๐ถ๐ฐ, look no further than the ๐ฒ๐๐ต ๐ ๐ฎ๐ฐ๐ฟ๐ผ๐ฝ๐ต๐ฎ๐ด๐ฒ-๐๐ถ๐ฟ๐ฒ๐ฐ๐๐ฒ๐ฑ ๐ง๐ต๐ฒ๐ฟ๐ฎ๐ฝ๐ถ๐ฒ๐ ๐ฆ๐๐บ๐บ๐ถ๐!
๐๐๐น๐น ๐๐ด๐ฒ๐ป๐ฑ๐ฎ ๐๐ฒ๐ฟ๐ฒ โก๏ธ https://ter.li/mio6hu
๐จ๐ป๐ถ๐๐ถ๐ป๐ด ๐ฒ๐ฌ+ ๐ฏ๐ถ๐ผ๐ฝ๐ต๐ฎ๐ฟ๐บ๐ฎ ๐ฎ๐ป๐ฑ ๐ฎ๐ฐ๐ฎ๐ฑ๐ฒ๐บ๐ถ๐ฎ ๐น๐ฒ๐ฎ๐ฑ๐ฒ๐ฟ๐ across R&D, discovery, biology, translational science, and clinical development, this is poised to be a must-attend event, deep-diving into the evolving macrophage-therapeutics landscape, exploring other indications, and tackling the most pressing industry challenges.๐ก
๐๐ผ๐๐ป๐น๐ผ๐ฎ๐ฑ ๐๐ต๐ฒ ๐๐๐น๐น ๐ฃ๐ฟ๐ผ๐ด๐ฟ๐ฎ๐บ โก๏ธ https://ter.li/mio6hu
This is an incredible opportunity to unlock the ful…
Following the watershed approval of Iovanceโs Lifileucel, all eyes are now on TIL therapies as the up-and-coming major therapeutic avenue for solid tumor treatment. Introducing the 6th Annual TIL Therapies Summit! With 30+ expert speakers, 12 new speaker companies, 2 brand-new content-filled tracks and 2 brand-new interactive workshops, you won't want to miss out! As the only meeting placing the entire spotlight on TIL drug development, this summit will unveil the latest to share clinical updates, next-generation candidates, manufacturing innovations, and assay characterizations to turbocharge development of the next wave of TIL therapies. Hear from TIL industry leaders like Iovance, MD Anderson Cancer Center, Obsidian Therapeutics, Steven Rosenbergโs group from the National Institute of H…
Events
Despite toxicity concerns for CD47 targets in 2023, the macrophage therapies space remains determined to drive revolutionary treatments for oncology, autoimmunity, inflammation, neurodegenerative disorders, and beyond. From pioneering the next generation of CAR-M therapies to unveiling novel targets, this field is on a mission to learn from the past and spearhead pipelines into clinical development.
With that, the 6th Macrophage-Directed Therapies Summit will return to Boston this year, uniting 60+ biopharma and academia leaders across R and D, Discovery, Biology, Translational, and Clinical Development fields. As a uniquely positioned platform, this event is perfect for those committed to reigniting excitement in macrophage pipeline advancement.
This is your chance to gain exclusive insig…
With Kenai Therapeutics emerging from stealth with an $82 Million Series A funding round, 2024 has started strong for iPSC drug developers looking to showcase the potential of their pipelines ahead of the next wave of investment.
The 4th iPSC Drug Development and Manufacturing Summit is your longest standing and definitive iPSC focused industry platform showcasing cutting-edge advances across R and D through to manufacturing and analytical development to help you stay at the forefront of the iPSC cell therapy revolution.
With content split across our Research and Development and Manufacturing and Analytical Development tracks, this is the one-stop shop meeting for drug developers and academic thought leaders looking to streamline their route to the clinic and scale up their manufacturing p…
The drive for at-home patient care, high-volume injectables and evolving regulations is driving the injectables landscape. Recent innovations from the FDA's groundbreaking human factor guidance for combination products to GSK's trailblazing strides in self-administered HIV medication, and MIT engineers' visionary work on implantable devices for diabetes, signal unparalleled momentum. The past 12 months have witnessed an electrifying surge in quality standards and ingenious device inventions, but challenges still persist in device design and development.
In 2024, with a renewed dedication to addressing key industry challenges, the 14th Injectables Summit stands as the premier gathering of experts, singularly committed to optimizing the journey of biopharma's injectable device development. F…
Attention all Macrophage Experts! ๐ข
If you're looking to learn from the past and ๐ฝ๐ฟ๐ผ๐ฝ๐ฒ๐น ๐๐ผ๐๐ฟ ๐บ๐ฎ๐ฐ๐ฟ๐ผ๐ฝ๐ต๐ฎ๐ด๐ฒ ๐๐ต๐ฒ๐ฟ๐ฎ๐ฝ๐ถ๐ฒ๐ ๐๐ผ ๐ฐ๐น๐ถ๐ป๐ถ๐ฐ, look no further than the ๐ฒ๐๐ต ๐ ๐ฎ๐ฐ๐ฟ๐ผ๐ฝ๐ต๐ฎ๐ด๐ฒ-๐๐ถ๐ฟ๐ฒ๐ฐ๐๐ฒ๐ฑ ๐ง๐ต๐ฒ๐ฟ๐ฎ๐ฝ๐ถ๐ฒ๐ ๐ฆ๐๐บ๐บ๐ถ๐!
๐๐๐น๐น ๐๐ด๐ฒ๐ป๐ฑ๐ฎ ๐๐ฒ๐ฟ๐ฒ โก๏ธ https://ter.li/mio6hu
๐จ๐ป๐ถ๐๐ถ๐ป๐ด ๐ฒ๐ฌ+ ๐ฏ๐ถ๐ผ๐ฝ๐ต๐ฎ๐ฟ๐บ๐ฎ ๐ฎ๐ป๐ฑ ๐ฎ๐ฐ๐ฎ๐ฑ๐ฒ๐บ๐ถ๐ฎ ๐น๐ฒ๐ฎ๐ฑ๐ฒ๐ฟ๐ across R&D, discovery, biology, translational science, and clinical development, this is poised to be a must-attend event, deep-diving into the evolving macrophage-therapeutics landscape, exploring other indications, and tackling the most pressing industry challenges.๐ก
๐๐ผ๐๐ป๐น๐ผ๐ฎ๐ฑ ๐๐ต๐ฒ ๐๐๐น๐น ๐ฃ๐ฟ๐ผ๐ด๐ฟ๐ฎ๐บ โก๏ธ https://ter.li/mio6hu
This is an incredible opportunity to unlock the ful…
There has been many exciting investments, collaborations and advancements in the field, for instance Capricor Therapeutics and the National Institutes of Health collaborate on a clinical trial for a novel exosome-based vaccine. However, delivery remains the biggest challenge so far for the RNA field, to get drugs to the right cell type with specificity, tolerability and effective targeting.
Hence, this October the 3rd Non-Viral RNA Delivery Systems Summit is being brought back to Boston as the first and only industry-led event focussed on non-viral delivery systems, such as LNPs, exosomes, polymers, peptides and more, for RNA payloads to advance potent and efficacious therapeutics towards the patients in need.
Join 80+ RNA delivery experts from the likes of AstraZeneca, Sanofi, Novo Nordis…
Europeโs largest conference for the drug discovery community returns to London, with scientific tracks covering not only therapeutic themes such as mechanisms of ageing and cell & gene therapy, but also more practical aspects of drug discovery encompassing advances in assay design, applications in high content imaging, target identification and disease modelling.
This yearโs Scientific Content Partners are the Cell & Gene Therapy Catapult, the Royal Society of Chemistry, SBi2 and SLAS, all of whom are providing science tracks prepared by their community members. And in the middle of all this science there is the exhibition hall, which is a great opportunity to meet over two hundred drug discovery suppliers and to learn about all the latest products and services you can use i…
Medical Device Project and Portfolio Management Conference: Strengthening Efficiency and Competitiveness Amid High Inflation
9th Edition of the Premier Industry Event to Be Held in Chicago
Event Date: October 2-4, 2024Location: Chicago, IL
Chicago, IL โ June 5, 2024 โ marcus evans is excited to announce the 9th Edition of the Medical Device Project and Portfolio Management conference, taking place from October 2-4, 2024, in Chicago, IL. This premier event is designed for project and portfolio management professionals in the medical device industry, focusing on maintaining a competitive edge during periods of high inflation by enhancing efficiency and strengthening portfolio management strategies.
Conference Overview:
In a time of economic challenges, particularly high inflation, the medica…
Increasingly, companies across Europe are recognizing the value of implementing Early Access Programmes to provide patients with access to life-changing medicines. However, challenges remain in adhering to a variety of cross-border regulations, clarifying rules around real-world data collection, and accurately anticipating supply volumes. To overcome these hurdles, it is essential for the industry to collaborate and share solutions.
Welcome to the 3rd Operationalise Early Access Programmes Summit Europe, dedicated to fostering open dialogue and sharing experiences in navigating the complex regulatory and operational landscape of Early Access Programmes. This October, join a community of over 140 experts in Access, Clinical Operations, Medical Affairs, and Clinical Supply from leading compa…
We extend a warm welcome to the Global Conference on Biosensors, where we will delve into the latest trends, applications, challenges, and advancements in the field. Our primary goal is to unite educators, experts, professionals, and research-oriented individuals in the biosensor sector to share profound knowledge for a brighter future through comprehensive discussions and presentations on key biosensor topics. We are thrilled to invite experts from across the globe to share their research insights, technological advancements, and perspectives on the most recent biosensor breakthroughs. This event offers a valuable opportunity for all attendees to gain essential knowledge about this rapidly evolving industry and explore the latest technologies and trends that are propelling growth and inno…
SAE Media Group presents the 5th Annual Wearable Injectors and Connected Devices Conference on October 14th-15th, 2024, in London, UK.
Explore on-body device design, connectivity, and digital health applications with industry insights from big pharma. Discover key developments in wearable injectors, including demand for on-body devices and digitalized health for at-home self-administration of time-dependent, high-volume drugs.
Engage with regulatory updates, user-experience considerations, and patient-centric device development. Network over two days, with 75% of speakers from big pharma, and gain insights into wearable injector technologies, regulatory processes, and connectivity implementation.
Join pharma, biotech, and device developers to discuss trends, challenges, and strategies. Lea…
With 128 TGF-B targeted therapies in the clinic and 68 in the preclinical stage, the TGF-B field is currently being rejuvenated by novel approaches in immuno-oncology, and cutting edge research in fibrosis, autoimmune diseases, and beyond.
The TGF-B Targeted Drug Development Summit returns to San Francisco for the 4th year to deep dive into the hottest topics in the field, such as combination strategies being employed by Genentech and discovering new and predictive biomarkers from Corbus Pharmaceuticals. This meeting will support you in securing clinical success with safe and efficacious TGF-B targeted therapies.
With a program consisting of TGF-B industry leaders such as Cue Biopharma, Synthis, and Pfizer, this year promises to spotlight innovative ways biotech and large pharma companies…
Are you listening to your patient community? It's not enough. Standing in the shadows and harvesting anecdotal insights won't build connections, create first-hand knowledge or illuminate your impact to internal stakeholders.
We must step forward and be visible, actively engaging in patient communities and embedding the patient voice internally. YOU are the patient advocate in your company, so overturn tokenistic gestures into meaningful actions that prioritize patients over patents.
This starts now. You must integrate and co-create from the outset, from clinical design to commercial execution to boost adherence, trial participation and create exceptional outcomes. Show that pharma is driven by more than profit - to build a world that empowers all patients and leaves no one in the dark. THI…
The Pharma Partnering Summit is an exclusive Life Sciences Industry event, with the aim to help companies expand their network and put together licensing deals, research collaborations and financing. Our platform brings together senior executives from different parts of the world specialising in Business Development & Licensing, Alliance Management, Research Collaborations, M&A and Investment. In addition to identifying products and partners as well as investors, the forum also serves to disseminate knowledge through expert speakers, for the best practices in the field of industry partnerships.
Registration Link: https://pharma-partnering-summit.com/registration.html
Artificial Intelligence (AI) is leading technological advancements in the pharmaceutical sector, poised to transform pre-clinical drug discovery by reducing costs by up to 40% and creating a market valued at up to $50 billion in the next decade. This transformative period is upon us, and the AI in Drug Discovery conference offers a unique opportunity to hear directly from experts and gain strategies to enhance your operations.
Scheduled for October 2024 in the United States, the AI in Drug Discovery Conference comes after a successful event in March 2024 in the UK. Since then, the industry has achieved a groundbreaking milestone: the first wholly AI-discovered and designed drug is now in Phase 2 clinical trials.
The conference is driven by the industry's shift towards personalized therapie…
22-Oct-2024 - 23-Oct-2024
The BioPharma Clinical Trials Nexus is an esteemed conference reserved for invited attendees, bringing together influential clinical trial decision makers and innovative suppliers and solution providers. Our agenda is meticulously crafted to tackle key challenges in clinical trials, explore emerging market trends, and highlight effective strategies deployed by industry leaders. This event serves as a prime opportunity for clinical trials service providers to engage in fruitful business development initiatives.
Key Notes:
Tackling Clinical Development Expenses & Obstacles: Insights from a Small Biopharma Viewpoint
Exploring New Perspectives in Modern Clinical Research
Empowering Clinical Operations Professionals: Harnessing AI to Enhance Outcomes
Unleashing the Vital Potential of Co…
Welcome to the 3rd BioPharma Site Solutions Summit the premier event that aims to tackle the critical challenges facing the clinical trial industry. Join us on 22nd - 23rd Oct in beautiful New Jersey as we bring together top-notch clinical leaders for two days of insightful discussions and innovative solutions. Our summit will dive into four key streams: Site Staffing and Retention, Patient Recruitment & Enrollment, Feasibility and Study Start-Up, and Clinical Trial Forecasting, Budgeting, and Partnerships. Get ready to connect, learn, and exchange ideas as we explore the cutting-edge strategies that optimize site performance and drive successful clinical trial.
Conference Topic:
Training and development strategies to ensure highly skilled and competent site workforce
โช Enhancing Diver…
Deliver a first-class customer journey.
It's getting harder to engage our customers.
More data is not translating into better customer interaction. Investments in tools and tech are not increasing face time. Every marketing, commercial and medical leader is striving to create the perfect, personalized customer journey, but one wrong step can lead to a 404 error message - your customer can no longer be found.
To regain our customers' time and trust, we must get better at predicting their unmet needs, their engagement preferences and their expectations of us, before they even know them themselves. We must pledge to provide consistent value first and foremost, through a data-backed, AI-powered, and customer-motivated engagement model. The future isn't that far away.
Join 350+ marketing, comme…
Following the watershed approval of Iovanceโs Lifileucel, all eyes are now on TIL therapies as the up-and-coming major therapeutic avenue for solid tumor treatment. Introducing the 6th Annual TIL Therapies Summit! With 30+ expert speakers, 12 new speaker companies, 2 brand-new content-filled tracks and 2 brand-new interactive workshops, you won't want to miss out! As the only meeting placing the entire spotlight on TIL drug development, this summit will unveil the latest to share clinical updates, next-generation candidates, manufacturing innovations, and assay characterizations to turbocharge development of the next wave of TIL therapies. Hear from TIL industry leaders like Iovance, MD Anderson Cancer Center, Obsidian Therapeutics, Steven Rosenbergโs group from the National Institute of H…
Join us for SAE Media Group's 2nd Annual RNA Therapeutics USA Conference on October 23-24, 2024, at Courtyard by Marriott Boston Downtown.
RNA therapies are at the forefront of genetic medicine, with the market projected to reach $1.81 billion by 2025. Explore mRNA vaccine advancements and regulatory successes shaping the field.
Discover the latest challenges and advancements in RNA delivery, particularly targeting the Central Nervous System. Uncover how RNA technologies are revolutionizing immunotherapies and vaccines, offering new hope for previously untreatable diseases.
Network with global experts from pharma and biotech, including Directors of RNA therapies, CEOs, scientists, and medical officers. Don't miss this opportunity to drive innovation in RNA therapeutics!
URLs:Tickets: …
The Ultimate Chance to Tackle Regulatory Challenges in the Cell and Gene Therapy Space!
With over 5,000 cell and gene therapies in pre-clinical and clinical development worldwide, regulatory clarity is crucial for developers striving for efficient and seamless approvals in their first regulatory submissions. Leading innovators are pioneering new approaches, like in vivo gene editing, rapidly pushing products from the clinic to commercialization. This rapidly evolving field is now on a mission to learn from case studies and glean insights from the forefront to optimize regulatory processes from pre-IND to approval.
Introducing the inaugural Cell and Gene Therapy Regulatory Affairs Summit in Washington D.C. This event will unite biopharma experts across non-clinical,clinical, and CMC regulat…
